Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock.
Launched by UNIVERSITY OF PECS · Nov 28, 2023
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • septic shock
- • intensive care unit administration
- Exclusion Criteria:
- • under age 18
- • above age 80
- • moribund patients
- • pregnant patients
- • active kidney stone
- • inability to obtain consent
- • viral or mixed sepsis
- • missed dose of vitamin C/ thiamin or hydrocortisone
- • Physician refused
- • Vitamin C / Thiamine/ Hydrocortisone for other indications
About University Of Pecs
The University of Pécs, a prestigious institution located in Hungary, is dedicated to advancing medical research and education through its innovative clinical trial initiatives. Renowned for its commitment to scientific excellence and interdisciplinary collaboration, the university actively engages in clinical studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on ethical standards and rigorous methodologies, the University of Pécs leverages its experienced faculty and state-of-the-art facilities to contribute valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pécs, Baranya, Hungary
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported